|
American Health News and
Wellness Report Newsletter
Prevention is a Cure (c)
NOVEMBER 2012- Vol 13 Issue 88 |
|
|
|
|
|
| Dear (Contact First Name), | |
Veterans Dinner and Senior Achievement Award
The Event was SOLD OUT! No more seats left.
Never before in 14 years have we seen this happen. We've almost tripled the number of seats sold and exceeded our expectations by the "wow" factor. The Senior Achievement/South Florida Veterans Night Dinner was an amazing success, in no part due to YOU, our supporters and sponsors. Thanks to everyone who partook in this event and we look forward to next year already.
Saturday, November 17th 2012 9:00 a.m.to 10:30 a.m.
You're Never Alone After Bereavement: A 50 and over group
now in its 14th year.
Heritage Park West Library
5859 Via Flora, Delray Beach
561 361 9091 $1 Donation
Sponsored by the Senior Foundation
A 501 (c) 3 Charity
Collecting toys, Clothes & Dental supplies for children in war zones (& civil unrest) countries worldwide. Since 2003, initially in Iraq and now in 28 countries, American Military Organization has shipped 1.5 million packages to children throughout the globe including the United States because of hurricanes, tornadoes Etc.
Sponsored by:The American Health Association & the American Military Organization
American Military Organization
c/o AMERICAN HEALTH SOCIETY
1181 South Rogers Circle, Suite 2
Boca Raton, FL. 33487
P 561 361 9091
F 561 368 7184
A 501 (c) 3 Charity made up of all volunteers for the public good |
|
|
|
| Low vitamin d levels = longevity? |  Low Vitamin D Levels=Longevity? (American Health Newswire) -- Vitamin D is used for conditions of the heart and blood vessels, including high blood pressure and high cholesterol. It is also used for diabetes, obesity, muscle weakness, multiple sclerosis, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), asthma, bronchitis, premenstrual syndrome (PMS), and tooth and gum disease. Researchers are now linking Vitamin D levels to longevity. To determine whether there was an association between vitamin D levels and longevity, Dutch researchers looked at data from 380 white families with at least 2 siblings over age 90 (89 years or older for men and 91 year or older for women) in the Leiden Longevity Study. The study involved the siblings, their offspring and their offsprings' partners for a total of 1038 offspring and 461 controls. The children of the nonagenarians were included because it is difficult to include controls for the older age group. The partners were included because they were of a similar age and shared similar environmental factors that might influence vitamin D levels. The researchers measured levels of 25(OH) vitamin D and categorized levels by month as they varied according to season. Tanning bed use, which can affect vitamin D levels, was categorized as never, 1 times per year and 6 times per year. The researchers controlled for age, sex, BMI (body mass index), time of year, vitamin supplementation and kidney function, all factors that can influence vitamin D levels. They also looked at the influence of genetic variation in 3 genes associated with vitamin D levels. "We found that the offspring of nonagenarians who had at least 1 nonagenarian sibling had lower levels of vitamin D than controls, independent of possible confounding factors and SNPs [single nucleotide polymorphisms] associated with vitamin D levels," Dr. Diana van Heemst, Department of Gerontology and Geriatrics was quoted saying. "We also found that the offspring had a lower frequency of common genetic variants in the CYP2R1 gene; a common genetic variant of this gene predisposes people to high vitamin D levels. These findings support an association between low vitamin D levels and familial longevity," Heemst continued. The findings postulate that offspring of nonagenarians might have more of a protein that is hypothesized to be an "aging suppressor" protein. More research is needed to understand the link between lower vitamin D levels, genetic variants and familial longevity. Source: Canadian Medical Association Journal, November 2012 |
| Killing cancer cells and protecting hearts |  Killing Cancer Cells and Protecting Hearts (American Health Newswire) - Approximately 12 million people had cancer in the United States in 2008 and that number has not stopped increasing. Scientists are now combining cancer medication with a drug for erectile dysfunction and another one for heart transplants, that helped kill cancer cells and still protected the heart from damage For decades, doxorubicin has been a powerful anti-cancer treatment for various human cancers, including breast, ovarian, colon and prostate. But its use has been limited due to harmful, possibly irreversible effects on the heart. In this study, using cell and animal models, researchers found that sildenafil alone or in combination with rapamycin (an immunosuppressant used to prevent post-transplant organ rejection) significantly improved the anti-cancer effects of doxorubicin while protecting the heart. The combination of all three medications showed the most powerful effect, researchers said. "Because sildenafil and rapamycin are clinically approved drugs that both protect heart muscle, we thought that combining these drugs with doxorubicin would be a unique strategy to eliminate the cardiac side effects of doxorubicin while further improving its cancer-killing ability," Rakesh Kukreja, Ph.D, professor of internal medicine and cardiology was quoted saying. "The drug combination led to a dramatic protection of heart muscle from apoptosis (cellular self-destruction) and, to a lesser extent, necrosis (cell death from disease)," David E. Durrant, study lead author was quoted saying. "We think this combination therapy may have excellent potential to move forward into clinical trials and eventually improve life expectancy of cancer patients. More research is needed to understand how sildenafil and rapamycin work together to improve doxorubicin treatment," Durrant continued. Source: The American Heart Association's Scientific Sessions 2012, November 2012 |
| Shrinking tumors without side effects! |
Shrinking Tumors without Side Effects!
(American Health Newswire) - If dealing with one diagnosis of cancer is not hard enough, imagine being told you have two different kinds of tumors. It's estimated 20 to 30 percent of women with advanced breast cancer develop secondary brain tumors, cancers that have spread to the brain from somewhere else in the body, and those with the HER-2 gene are most at risk. Now, new research shows two drug combinations could shrink those tumors with minimal side effects.
"As women live longer with advanced cancer the occurrence of brain metastases is becoming increasingly common," Thomas Bachelot from the Centre Léon Bérard in Lyon, France, who led the research, was quoted as saying. "Traditionally, most of these women receive WBRT which can impair cognitive function. "
The study conducted by the French cooperative group UNICANCER found the combination of lapatinib and capecitabine had similar responses rates to whole brain radiation therapy.
"Delaying such a treatment for those patients is potentially a big advance," Bachelot was quoted as saying.
They tested 45 patients, all with previously untreated brain metastases from HER2-positive breast cancer who were treated with a daily combination of lapatinib and capecitabine. Researchers found the combination shrunk brain tumours by at least 50% in two-thirds of women with advanced HER2-positive breast cancer, with a fifth of patients experiencing at least 80% reduction in tumour size, but with manageable side effects.
About half of patients experienced at least one grade 3 or 4 side effect, the most common being diarrhea and hand-foot syndrome, leading to treatment discontinuation in four women.
"This strategy deserves further evaluation to confirm the clinical benefits in terms of survival, cognitive function, and quality of life," Bachelot was quoted as saying.
Scientists from the Medical University of Vienna in Austria suggest the findings are very significant and some women could be spared from having radiotherapy.
"For patients with multiple brain metastases from HER2-positive breast cancer presenting with minimal clinical symptoms and good performance status, primary systemic treatment containing lapatinib and capecitabine might already be a valid treatment option," they were quoted as saying.
Source: Lancet Oncology .
|
| It's ELF time |  The 2012 Elf Project Registration for the Fall -Winter 2012 Elf Campaign is on now. Call 561 361 9091 to start signing up as a potential elf. We Visit Hospitals & Nursing homes in Palm Beach & Broward Counties giving Christmas gifts to all. nursing home residents & hospital patients. Sponsored by The Senior Foundation & American Health Society |
|
|
100% of every dollar goes to service the charities programs and services here in Palm Beach County and around the globe Not one cent in 8 years has ever gone to salaries, of any kind, to anyone. We are, from top to bottom all volunteers in service to the community. |
|
MISSION STATEMENT
The American Health Society is a distinguished 13 year old multi-award winning preventative public health & wellness 501(c)(3) charity whose mission is in preventative healthcare, mental wellness, health education, literacy and advocacy aimed at preventing lifestyle based illnesses, diseases and the frailties of aging.
We have a strong "Social Green Philosophy" of Humanitarian Service through our American Volunteer Corps which has a global outreach in 46 countries with members in 37 US States.
J. Robert Gordon - CEO and Founder American Health Association
561-361-9091 |
|
|
|
|
